Below are the most recent publications written about "Stroke Volume" by people in Profiles.
-
Segan L, Kistler PM, Nanayakkara S, Taylor A, Hare J, Costello B, Chieng D, Crowley R, William J, Sugumar H, Cho K, Voskoboinik A, Ling LH, Nderitu Z, Azzopardi S, Curtin A, Premaratne M, McLellan AJ, Mariani J, Morton JB, Lee G, Joseph S, Reid C, Kaye DM, Kalman JM, Prabhu S. Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial. Eur Heart J. 2026 Jan 07; 47(2):250-262.
-
Baskaran P, Aldhaeefi M, Asaadi A, Jones M, King E, Rungkitwattanakul D, Wingate L. Empagliflozin and hydralazine-isosorbide dinitrate combination therapy improves outcomes in Black patients with heart failure. Int J Clin Pharmacol Ther. 2025 Nov; 63(11):553-556.
-
Goldenberg I, Zareba W, Ezekowitz JA, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Harrington JM, Hsich E, Huang DT, Januzzi JL, Jawaid A, Kutyifa V, Lala-Trindade A, Nakonechnyi A, Onwuanyi A, Pi?a IL, Sandhu RK, Sears S, Sroubek J, Baykaner T, Strawderman R, Beck C, Butler J. Rationale and design of the comparative effectiveness of ICD vs non-ICD therapy in contemporary heart failure patients at a low risk for arrhythmic death (CONTEMP-ICD) trial. Am Heart J. 2026 Jan; 291:162-174.
-
Papapostolou S, Kearns JS, Costello B, O'Brien J, Gutman S, Nanayakkara S, Kaye DM, Walton A, Hare J, Stub D, Taylor A. Relationship between left ventricular wall stress and cardiac remodelling post-TAVR and MitraClip. Open Heart. 2025 Aug 31; 12(2).
-
Loayza Pintado J, Ajani T, Hernandez D, Cobos E. A Rare Culprit or an Elusive Culprit in Disguise? Unraveling Wild-Type ATTR Cardiac Amyloidosis in Heart Failure With Reduced Ejection Fraction. J Investig Med High Impact Case Rep. 2025 Jan-Dec; 13:23247096251345712.
-
Rosano GMC, Teerlink JR, Kinugawa K, Bayes-Genis A, Chioncel O, Fang J, Greenberg B, Ibrahim NE, Imamura T, Inomata T, Kuwahara K, Moura B, Onwuanyi A, Sato N, Savarese G, Sakata Y, Sweitzer N, Wilcox J, Yamamoto K, Metra M, Coats AJS. The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS). Eur J Heart Fail. 2025 Jul; 27(7):1174-1187.
-
Ren J, Bloom JE, Chan W, Reid CM, Smith JA, Taylor A, Kaye D, Royse C, Tian DH, Bowyer A, El-Ansary D, Royse A. Survival Outcomes After Multiple vs Single Arterial Grafting Among Patients With Reduced Ejection Fraction. JAMA Netw Open. 2025 04 01; 8(4):e254508.
-
Gao YP, Liu HY, Bi XJ, Sun J, Zhu Y, Zhou W, Fan YT, Cheng XQ, Huang PN, Liu YN, Deng YB. H2FPEF and HFA-PEFF scores for heart failure risk stratification in hypertrophic cardiomyopathy patients. ESC Heart Fail. 2025 Jun; 12(3):2225-2238.
-
Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Pi?a IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. J Card Fail. 2025 Aug; 31(8):1326-1338.
-
Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Pi?a IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. Heart Rhythm. 2025 Apr; 22(4):1040-1051.